This stock is way undervalued, especially compared to Cannabix. Cannabix is infinitely less likely to become successful with faims and breathtec not only is using faims to identify abundant compounds that are much easier to detect, but breathtec also has Na-nose which is government tested and is in clinical trials (approved).
Yet it trades for a quarter of Cannabix. People overlook scientific fact and data and invest on the theory of a device. It's silly.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.